Yilei Sheng
Nanchang, 330031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies.
Journal: Discover oncology
Published: December 22, 2024
β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.
Journal: Bioactive materials
Published: July 02, 2024
Identification of TAP2 as a novel immune target in human cancers: insights from integrated bioinformatics and experimental approaches.
Journal: European journal of medical research
Published: June 08, 2024
Deep learning-assisted detection and segmentation of intracranial hemorrhage in noncontrast computed tomography scans of acute stroke patients: a systematic review and meta-analysis.
Journal: International journal of surgery (London, England)
Published: December 19, 2023
Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG).
Journal: Heliyon
Published: October 11, 2023
Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.
Journal: Aging
Published: July 05, 2023
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 20, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026